Study found when woman's uterus, ovaries had been exposed at young age, risk was up to 12 times greater
By Steven ReinbergHealthDay Reporter
THURSDAY, July 22 (HealthDay News) -- Women who are childhood cancer survivors face a greater risk of having a stillborn child if their uterus or ovaries were exposed to radiation during their treatments, a new study finds.
Although neither boys nor girls who survived childhood cancer appear to suffer...
Women who regularly take fish oil supplements containing omega-3 fatty acids significantly reduce their risk of getting breast cancer, according to research.
The chance of developing the most common form of the disease, invasive duct breast cancer, is reduced by 32% among women who regularly take the supplements, scientists found in the latest study. However, other supplements taken by women for menopausal symptoms fail to offer any protection....
HOLOGIC DIGITAL MAMMOGRAPHY SYSTEM IS FIRST TO RECEIVE EUREF “MAMMOGRAPHIC TYPE TEST” CERTIFICATION
Certification ensures users that the Hologic Selenia system meets or exceeds rigorous European image quality and dose standards
BEDFORD, Mass. (June 22, 2010) /PRNewswire/ — Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving...
Breast Cancer Reconstruction Using Cell-Enriched Fat Grafts Shows Continued High Rates of Physician and Patient Satisfaction at 12 Months
Interim Data Presented at British Oncoplastic Surgery Meeting; Complete 12-Month Results Expected in Early 2011
SAN DIEGO--(BUSINESS WIRE)--Interim results from a breast reconstruction trial show stem and regenerative cell-enriched fat grafting resulted in a high sustained rate...
ScienceDaily (June 9, 2010) — Researchers at UT Southwestern Medical Center have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.
"Further down the line we could create a drug that would bring COMMD1 protein levels back to normal, or even above normal, in the tumor to hopefully affect cancer cell invasion," said Dr. Ezra Burstein, assistant professor of internal...
